Healio

First patient dosed in phase 3 vilobelimab trial for pyoderma gangrenosum

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Ulcerative pyoderma gangrenosum is a rare disease with ...
Healio

Patients with pyoderma gangrenosum experience higher mortality rates

Please provide your email address to receive an email when new articles are posted on . Patients with pyoderma gangrenosum are at greater risk of all-cause and cause-specific mortality compared with ...
The Sun

‘It’s like someone is wiggling a red hot poker through my legs,’ says man, 49, who is ‘red and oozing like raw meat’

Robert has to wrap his legs so tightly it feels "like an elastic band" ROBERT Lilley was diagnosed with a rare flesh-eating condition 12 years ago – and has lived in “unbearable pain” ever since. The ...
manilatimes

InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...